Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methodsReview Published on 2024-04-182024-09-05 Journal: mAbs [Category] update2024, [키워드] monoclonal antibodies multiclonal antibodies non-animal derived antibodies, phage display, 3R, immunoglobulin, library, somatic hypermutation polyclonal antibodies recombinant antibodies [DOI] 10.1080/19420862.2024.2343499 PMC 바로가기 [Article Type] Review
Sandwich ELISA for the Quantification of Nucleocapsid Protein of SARS-CoV-2 Based on Polyclonal Antibodies from Two Different SpeciesArticle Published on 2023-12-262024-09-05 Journal: International Journal of Molecular Sciences [Category] update2024, [키워드] antigen test COVID-19 diagnosis ELISA nucleocapsid protein polyclonal antibodies [DOI] 10.3390/ijms25010333 PMC 바로가기 [Article Type] Article
Production of anti-PfEMP1 Polyclonal Antisera in Rats and Micearticle Published on 2022-12-312024-09-01 Journal: Methods in molecular biology (Clifton, N.J.) [Category] 말라리아, [키워드] adhesion Antisera immunization malaria mice PfEMP1 Plasmodium falciparum polyclonal antibodies protein antigen RATs [Article Type] article
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialArticle Published on 2022-11-082022-11-16 Journal: Trials [Category] SARS, 변종, [키워드] adaptive anti-COVID-19 IVIG antivirals clinical evidence clinical trial collected convalescent convalescent plasma COVID-19 cumulative death Efficacy eligibility criteria evaluate Health hyperimmune immunization immunomodulators intravenous Intravenous immunoglobulin low dose monoclonal antibodies Neutralizing non-specific novel Novel coronavirus outcome Passive passive immunization Patient phase Pneumonia polyclonal polyclonal antibodies Pooled convalescent plasma Potential treatment Randomized Randomized controlled trial receive Recovered COVID-19 patients reported SARS CoV-2 SARS-CoV-2 sealed Secondary outcomes severe COVID-19 severe COVID-19 patient severe COVID-19 patients Standard of care Steroids Study protocol therapeutic option therapy treat Treatment Trial variant variants of concern virus virus particles World Health Organization [DOI] 10.1186/s13063-022-06860-2 PMC 바로가기
Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virusSARS-CoV-2, MERS-CoV, 에볼라, 지카, HIV-1 및 인플루엔자 A 바이러스에 특히 중점을 두고 중요한 신흥 바이러스 병원체에 대응하는 강력한 생물 치료제로서의 형질전환 소 유래 광범위 중화 항체Review Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adjuvant adjuvants Alpha animals antibody antibody-based therapies Antiviral approach approved assist Beta Biotherapeutics blocked bovine bovine-derived biotherapeutics Clinical studies colostrum convalescent coronavirus creating Delta disease Donor E484K Ebola effective Efficiency emerging viruses Epsilon Gamma highlight HIV-1 Human Human immunodeficiency virus human immunodeficiency virus type 1 human infection human infections hyperimmunization immune immunoreactivity Immunotherapy Influenza influenza A influenza A virus Iota K417N L452R Lambda MERS MERS-CoV Middle East Middle East respiratory syndrome Coronavirus mutations N501Y neutralization neutralized Neutralizing Neutralizing activity neutralizing antibody omicron Omicron variants outbreak P681R Pandemics platform polyclonal antibodies polyclonal antibody produced Protective respiratory respiratory syndrome coronavirus robust Safe SARS-CoV-2 serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 shown T478K therapeutic option transchromosomic bovines. Vaccine variant variants variants of concern variants of interest Viral viral infection viral infections viral pathogen VOCs VOIs Zika [DOI] 10.1002/jmv.27907 PMC 바로가기 [Article Type] Review
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2Article Published on 2022-08-152022-11-16 Journal: Frontiers in Immunology [Category] SARS, 변종, [키워드] ACE2 receptor binding addition administration antibody Beta clearance contributed country COVID-19 COVID-19 pandemic creating delta variant disease dose doses Efficacy emergence EpF(ab’)2 equine Equine F(ab’)2 Fab HBsAg immunization implementation increased survival Infection intranasal K18-hACE2 K18-hACE2 transgenic mice mice monoclonal antibody treatment neutralize omicron outcome pandemic passive immunization peripheral circulation phenotype polyclonal polyclonal antibodies PROTECT RBD SARS-CoV-2 SARS-COV-2 infection Severe case severe disease severe SARS-CoV-2 strain survival tested therapeutic Therapeutic treatment tissues transgenic Treatment variant variant of concern (VOC) variants variants of concern variants of SARS-CoV-2 Viral RNA virus VoC [DOI] 10.3389/fimmu.2022.948431 PMC 바로가기
Template-Based Assembly of Proteomic Short Reads For De Novo Antibody Sequencing and Repertoire ProfilingDe Novo 항체 시퀀싱 및 레퍼토리 프로파일링을 위한 Proteomic Short Read의 템플릿 기반 어셈블리Review Published on 2022-07-262022-09-11 Journal: Analytical Chemistry [Category] MERS, 유전자 메커니즘, 진단, [키워드] Accuracy antibody antibody repertoire antibody sequence antibody sequences antigens assembly B-cells cDNA sequencing complementary dataset de novo disease Fab feature fluids foundation functional Health homologous homologous antibody hypermutation IgG information light chains Liquid chromatography mass mass spectrometry molecular monoclonal antibody offer Patient patients hospitalized polyclonal polyclonal antibodies polyclonal antibody Profiling proteomic provide Read Recombination repertoire secreted sequence Sequencing sera serological assays serum step Stitch Urine with COVID-19 [DOI] 10.1021/acs.analchem.2c01300 PMC 바로가기 [Article Type] Review
Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteinsSARS-CoV-2 감염에 대한 비용 효율적인 양 항체 기반 요법의 개발 및 스파이크 소단위 단백질에 대한 항체의 기여Article Published on 2022-07-012022-09-11 Journal: Antiviral Research [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] affinity antibodies antibody Antibody titre antibody-based therapy Antigen approval approved B.1.1.529 complement complement fixation convalescent plasma COVID-19 demonstrated development evaluated fixation generate highly active Immunoglobulin in vitro Neutralising activity omicron performed phagocytosis plasma polyclonal antibodies polyclonal antibody protective immunity Protein provide raised Regulatory S1 and S2 S2 subunit SARS-CoV-2 SARS-CoV-2 disease SARS-COV-2 infection sheep Spike protein subunit therapy therapy for COVID-19 variant virus was collected widespread [DOI] 10.1016/j.antiviral.2022.105332 PMC 바로가기 [Article Type] Article
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization항체 중화에 대한 SARS-CoV-2 람다 변이체의 내성 증가Article Published on 2022-06-012022-09-11 Journal: Journal of Clinical Virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] addition affecting antibody Antibody neutralization binding class Combination contributed convalescent plasma country defined elicited evaluated immunization Inactivated vaccine Increased Lambda Lambda variant monoclonal antibody NAb natural infection neutralization neutralization test plasma polyclonal antibodies polyclonal antibody RBD of SARS-CoV-2 reduced SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant sensitivity significantly Spike protein spread to Structure Substitution suggested the RBD variant Viral viral mutation [DOI] 10.1016/j.jcv.2022.105162 PMC 바로가기 [Article Type] Article
High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infectionSARS-CoV-2 감염 회복 후 인간의 장기 혈청 항체에 대한 고해상도 분석Article Published on 2022-05-312022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 진단, 치료법, [키워드] Accuracy aligned Analysis antibody Antibody Response antibody tests Antibody titer Antibody titers binding site Biomarker Blood Complete contribute convalescent serum COVID-19 diagnostic Diagnostic accuracy domain dominant epitope epitope Epitopes evaluated full-length full-length spike protein high-density Human identify Immunity Infection maintenance membrane protein neutralize nucleoprotein peptide peptide microarray polyclonal antibodies polyclonal antibody Previous studies previous study proteome provide reactivity Region representing resolved response SARS-CoV-2 SARS-COV-2 infection serological serum antibodies serum antibody spike epitope spike epitopes Spike protein Viral [DOI] 10.1038/s41598-022-12032-8 PMC 바로가기 [Article Type] Article